These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12223955

  • 1. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].
    Bron A.
    J Fr Ophtalmol; 2002 Jun; 25(6):641-54. PubMed ID: 12223955
    [Abstract] [Full Text] [Related]

  • 2. [Update on prospective glaucoma intervention studies].
    Arend KO, Redbrake C.
    Klin Monbl Augenheilkd; 2005 Oct; 222(10):807-13. PubMed ID: 16240274
    [Abstract] [Full Text] [Related]

  • 3. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L, Leske MC.
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [Abstract] [Full Text] [Related]

  • 4. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.
    Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT.
    BMJ; 2005 Jul 16; 331(7509):134. PubMed ID: 15994659
    [Abstract] [Full Text] [Related]

  • 5. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK.
    Curr Opin Ophthalmol; 2006 Apr 16; 17(2):138-41. PubMed ID: 16552248
    [Abstract] [Full Text] [Related]

  • 6. Initial management of ocular hypertension and primary open-angle glaucoma: an evaluation of the royal college of ophthalmologists' guidelines.
    Choong YF, Devarajan N, Pickering A, Pickering S, Austin MW.
    Eye (Lond); 2003 Aug 16; 17(6):685-90. PubMed ID: 12928677
    [Abstract] [Full Text] [Related]

  • 7. Incorporating corneal pachymetry into the management of glaucoma.
    Iester M, Mete M, Figus M, Frezzotti P.
    J Cataract Refract Surg; 2009 Sep 16; 35(9):1623-8. PubMed ID: 19683164
    [Abstract] [Full Text] [Related]

  • 8. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
    Bron A, Nordmann JP, Baudouin C, Rouland JF, Kadi A, Sartral M.
    J Fr Ophtalmol; 2003 Nov 16; 26(9):895-903. PubMed ID: 14631273
    [Abstract] [Full Text] [Related]

  • 9. [Long-term results after selective laser trabeculoplasty -- a clinical study on 269 eyes].
    Best UP, Domack H, Schmidt V.
    Klin Monbl Augenheilkd; 2005 Apr 16; 222(4):326-31. PubMed ID: 15844043
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb 16; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 11. The impact of risk calculation on treatment recommendations made by glaucoma specialists in cases of ocular hypertension.
    Boland MV, Quigley HA, Lehmann HP.
    J Glaucoma; 2008 Dec 16; 17(8):631-8. PubMed ID: 19092458
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul 16; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 13. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP, Domack H, Schmidt V.
    Klin Monbl Augenheilkd; 2007 Mar 16; 224(3):173-9. PubMed ID: 17385117
    [Abstract] [Full Text] [Related]

  • 14. The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator.
    Mansberger SL, Cioffi GA.
    J Glaucoma; 2006 Oct 16; 15(5):426-31. PubMed ID: 16988606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW, Low-Pressure Glaucoma Study Group.
    Ophthalmology; 2005 Mar 16; 112(3):376-85. PubMed ID: 15745762
    [Abstract] [Full Text] [Related]

  • 17. [Prevalance of open angle glaucoma and ocular hypertension as a risk factor for primary open angle glaucoma in Wroclaw population. Wroclaw Epidemiology Study].
    Nizankowska MH, Kaczmarek R.
    Klin Oczna; 2004 Mar 16; 106(1-2 Suppl):147-52. PubMed ID: 15510479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ, Simmons ST, Craven ER.
    Curr Med Res Opin; 2007 Dec 16; 23(12):2971-83. PubMed ID: 17949534
    [Abstract] [Full Text] [Related]

  • 20. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I, EGPS Group.
    Am J Ophthalmol; 2007 Aug 16; 144(2):266-275. PubMed ID: 17543874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.